Skip to main content
IMS Events Main banner
Back

    Michel Delforge, MD/Phd (he/him/his)

    Professor of Medicine
    University of Leuven, Leuven, Belgium
    Leuven, Belgium

    Michel Delforge, MD, PhD, is a professor of medicine in the Department of Haematology at the University of Leuven, in Leuven, Belgium. He studied medicine at the University of Leuven, where he obtained a doctoral degree in biomedical sciences. He continued his medical training as a research fellow at the University of Minnesota, Minneapolis, MN, USA, and subsequently undertook a clinical fellowship at the University of Leuven, with specific interests in myelodysplastic syndromes and plasma cell diseases.
    Professor Delforge is director of the KU Leuven Cancer Institute and Clinical Head of the Department of Haematology at the University Hospital Leuven, where he directs the plasma cell dyscrasia unit.with a major focus on multiple myeloma and AL amyloidosis.
    Professor Delforge is the current chair of the Myeloma Committee of the Belgian Hematology Society and a member of several international societies in the field of plasma cell dyscrasias. His specific interests are on management of treatment-related adverse events, quality of life and mechanisms of drug resistance.

    Disclosure information not submitted.

    Presentation(s):